Resting levels of fibrinolysis in blood in inactive and exercising men. 1970

T R Moxley, and P Brakman, and T Astrup

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000933 Antifibrinolytic Agents Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. Antifibrinolysin,Antifibrinolysins,Antifibrinolytic,Antifibrinolytic Agent,Antiplasmin,Antiplasmins,Antifibrinolytics,Plasmin Inhibitor,Plasmin Inhibitors,Agent, Antifibrinolytic,Agents, Antifibrinolytic,Inhibitor, Plasmin,Inhibitors, Plasmin

Related Publications

T R Moxley, and P Brakman, and T Astrup
April 1974, Journal of applied physiology,
T R Moxley, and P Brakman, and T Astrup
August 1977, Journal of applied physiology: respiratory, environmental and exercise physiology,
T R Moxley, and P Brakman, and T Astrup
June 1982, Journal of applied physiology: respiratory, environmental and exercise physiology,
T R Moxley, and P Brakman, and T Astrup
May 1977, Aviation, space, and environmental medicine,
T R Moxley, and P Brakman, and T Astrup
July 1999, Journal of applied physiology (Bethesda, Md. : 1985),
T R Moxley, and P Brakman, and T Astrup
March 1988, Journal of applied physiology (Bethesda, Md. : 1985),
T R Moxley, and P Brakman, and T Astrup
September 1996, Journal of applied physiology (Bethesda, Md. : 1985),
T R Moxley, and P Brakman, and T Astrup
July 1999, Journal of applied physiology (Bethesda, Md. : 1985),
T R Moxley, and P Brakman, and T Astrup
October 1980, Clinical toxicology,
T R Moxley, and P Brakman, and T Astrup
June 1999, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!